International
The Morning Science

What science found today

‹
 

Research

CLEC2D orchestrates immune evasion and intrinsic oncogenic signals to fuel triple-negative breast cancer

Nature ·

The Brief

  • A Nature Communications-family paper (s42003-026-11357-8) reports that CLEC2D is involved in immune evasion in triple-negative breast cancer.
  • The same study describes CLEC2D as contributing to intrinsic oncogenic signalling in this cancer subtype.
  • The source material available is a journal feed listing with the title only, so the methods and results are not summarised here.

Why it matters

Triple-negative breast cancer lacks the hormone-receptor and HER2 targets used in other breast cancers, so identifying molecules that help tumours evade immunity and drive growth may point to new research directions.

Who’s affected

  • breast cancer researchers
  • cancer immunologists
  • oncology drug developers

How do you feel about this?

0 Comments

    CLEC2D orchestrates immune evasion and intrinsic oncogenic signals to fuel triple-negative breast cancer – The Morning Science